IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 1 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,865,203 | -5.6% | 1,384,686 | +9.0% | 4.88% | -17.1% |
| Q2 2023 | $76,156,635 | +36.8% | 1,270,124 | +12.8% | 5.88% | +11.5% |
| Q1 2023 | $55,682,097 | +13.7% | 1,126,256 | +31.3% | 5.28% | -8.2% |
| Q4 2022 | $48,961,780 | +34.9% | 857,925 | +11.0% | 5.75% | +18.8% |
| Q3 2022 | $36,288,000 | +45.7% | 773,079 | +15.8% | 4.84% | -2.6% |
| Q2 2022 | $24,901,000 | +66.8% | 667,417 | +33.7% | 4.96% | +25.8% |
| Q1 2022 | $14,926,000 | +224.7% | 499,190 | +271.8% | 3.95% | +200.6% |
| Q4 2021 | $4,597,000 | – | 134,249 | – | 1.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $21,500,000 | 16.53% |
| Velan Capital Investment Management LP | 293,385 | $10,946,000 | 11.10% |
| Paradigm Biocapital Advisors LP | 667,417 | $24,901,000 | 4.96% |
| RTW INVESTMENTS, LP | 3,996,154 | $149,097,000 | 3.85% |
| Rock Springs Capital Management LP | 2,671,652 | $99,679,000 | 2.90% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $14,387,000 | 2.18% |
| Samsara BioCapital, LLC | 160,963 | $6,006,000 | 1.60% |
| Avidity Partners Management LP | 1,350,000 | $50,369,000 | 1.16% |
| Pier Capital, LLC | 123,394 | $4,604,000 | 0.78% |
| Omega Fund Management, LLC | 51,535 | $1,923,000 | 0.61% |